四层大会堂A区
2023-6-30 10:00-11:30
Moderator 主持 |
Shaoliang Chen 陈绍良 (江苏南京市第一医院)Yida Tang 唐熠达 (北京大学第三医院) |
||
---|---|---|---|
Discussant 讨论 |
Murray Esler (Baker Heart and Diabetes Institute)Feng Cao 曹丰 (解放军总医院)Feng Xu 许峰 (北京医院)Jun Jiang 蒋峻 (浙江大学医学院附属第二医院)Haibo Jia 贾海波 (哈尔滨医科大学附属第二医院)Rongchong Huang 黄榕翀 (首都医科大学附属北京友谊医院)Xiao Wang 王晓 (首都医科大学附属安贞医院)Junqing Yang 杨峻青 (广东省人民医院)Hanjun Zhao 赵汉军 (中国医学科学院阜外医院) |
||
10:00-10:12 |
A prospective, multi-center, blinded, randomized controlled trial of the safety and effectiveness of the Iberis® multi-electrode renal artery radiofrequency ablation catheter system for the treatment of primary hypertension (Iberis-HTN)
|
Xiongjing Jiang 蒋雄京 (中国医学科学院阜外医院) |
|
10:12-10:18 |
Discussion
|
||
10:18-10:30 |
Pivotal trial of targeted renal denervation to treat hypertension: SMART Study
|
Yong Huo 霍勇 (北京大学第一医院) |
|
10:30-10:36 |
Discussion
|
||
10:36-10:48 |
Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: a multicentre, randomised, sham-controlled trial
|
Lei Song 宋雷 (中国医学科学院阜外医院) |
|
10:48-10:54 |
Discussion
|
||
10:54-11:06 |
Effectiveness and safety of a novel intravascular shockwave lithotripsy system for severe coronary calcification: The CALCI-CRACK trial
|
Yan Li 李妍 (空军军医大学唐都医院) |
|
11:06-11:12 |
Discussion
|
||
11:12-11:24 |
12 months Primary Outcome from a Prospective Patient-level Pooled Analysis of the Novel Thinner Strut Firesorb Sirolimus-eluting Bioresorbable Scaffold for the Treatment of De novo Coronary Artery Disease
|
Jian-an Wang 王建安 (浙江大学医学院附属第二医院) |
|
11:24-11:30 |
Discussion
|